Global Nasal Drug Delivery Market, By Drug Type (Anesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, Others), Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels and Ointments, Nasal Powders, Others), Container Type (Non-Pressurized Containers, Pressurized Containers), System Type (Multi-Dose, Bi-Dose, Unit Dose), Therapeutic Application (Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), End User (Hospitals, Clinics, Home Care Settings), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029
Market Analysis and Insights Global Nasal Drug Delivery Market
Data Bridge Market Research analyses that the nasal drug delivery market to be grow at a CAGR of 6.88% in the forecast period of 2022-2029 and is likely to reach the USD 95.27 billion by 2029.
Nasal drug delivery refers to the administration of medication through the nasal to treat a variety of respiratory issues, including paranasal sinusitis, nasal infection, and other nasal issues. It is an adequate way to deliver drugs that are active at low concentrations. The drugs can be taken in a variety of ways, including via eating, absorption, inhalation, skin absorption, and intravenous injection. Drug delivery devices, which are specialized tools for delivering a therapeutic substance through a specific device type, are designed for this purpose. The pace at which a medicine is delivered and the place in the body where it is distributed are both controlled by drug delivery systems.
The rising patient preference for nasal drug delivery as a result of easy administration and better efficiency will act as major driver accelerating the nasal drug delivery market’s growth rate. The rising adoption of self-administration practices will increase the demand for nasal drug delivery and further propel the market’s growth rate. Another significant factor resulting in the expansion of market is the rising focus on the development of smart/digital inhalers. Furthermore, surging healthcare expenditure and increasing demand for painless drug administration are the major drivers that will enhance the growth of market. Likewise, rise in the number of cases of respiratory disorders such as asthma and others will show positive impact on the market’s growth rate. Rapid urbanisation, changing lifestyle and rise in the level of disposable incomes in developing and developed countries will influence the growth rate of nasal drug delivery market. The rise in the number of geriatric population and increase in the demand for home healthcare devices will flourish the growth rate of nasal drug delivery market.
Moreover, the rise in the number of research and development activities associated with nasal drug delivery and advancement in nasal drug delivery device technology will provide beneficial opportunities for the nasal drug delivery market growth. Additionally, the increasing demand from emerging markets and the development of over-the-counter (OTC) drugs by various pharmaceutical companies will further expand the nasal drug delivery market’s growth rate in the future.
On the other hand, high cost associated with drug delivery devices and complexities linked with the overuse of nasal sprays such as infection, nausea and irritation will obstruct the market growth. Also, low bioavailability and irreversible damage of cilia of cell and intense competition among market players will challenge the nasal drug delivery market. However, patents expiry of several drugs and less awareness will act as restrain and further impede the growth rate of market.
This nasal drug delivery market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on nasal drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Nasal Drug Delivery Market Scope and Market Size
The nasal drug delivery market is segmented on the basis of drug type, dosage form, container type, system type, therapeutic application, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on drug type, the nasal drug delivery market is segmented into anesthetics, antibiotics, pain relief drugs, calcium supplements, vasoconstrictors, antihistamines and others.
- Based on dosage form, the nasal drug delivery market is segmented into nasal spray, nasal drops, nasal gels and ointments, nasal powders and others.
- Based on container type, the nasal drug delivery market is segmented into non-pressurized containers and pressurized containers.
- Nasal drug delivery market, on the basis of system type has been segmented into multi-dose, bi-dose and unit dose.
- On the basis of therapeutic application, the nasal drug delivery market is segmented as allergic and non-allergic rhinitis, nasal congestion, asthma, vaccination and others.
- On the basis of distribution channel, the nasal drug delivery market is segmented as hospital pharmacies, retail pharmacies and online pharmacies.
- Nasal drug delivery market has also been segmented based on the end user into hospitals, clinics and home care settings.
Nasal Drug Delivery Market Country Level Analysis
The nasal drug delivery market is analysed and market size insights and trends are provided by country, drug type, dosage form, container type, system type, therapeutic application, distribution channel and end user as referenced above.
The countries covered in the nasal drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the nasal drug delivery market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period of 2022-2029. This is due to the presence of major key players and well-established healthcare infrastructure in this region. Additionally, the increase in the prevalence of rhinitis, sinusitis, congestion and respiratory allergic reactions will further propel the market’s growth rate in this region. Asia-Pacific on the other hand is projected to exhibit the highest growth rate during the forecast period of 2022-2029 due to the growing number of geriatric population and the rising incidences of allergy diseases in this region.
The country section of the nasal drug delivery market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The nasal drug delivery market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for nasal drug delivery market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the nasal drug delivery market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Global Nasal Drug Delivery Market Share Analysis
The nasal drug delivery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to nasal drug delivery market.
Some of the major players operating in the nasal drug delivery market are Johnson & Johnson Private Limited, Bausch Health Companies Inc., Merck & Co., Inc., Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Mystic Pharmaceuticals, BD, 3M, AptarGroup, Inc., OptiNose US, Inc., Dr. Reddy’s Laboratories Ltd., Cadila Pharmaceuticals, PendoPharm Inc., Neurelis, Inc., Sanofi, Novartis AG, Teva Pharmaceutical Industries Ltd., Recipharm AB, and Vectura Group plc, among others.